Person
Ben Sasse
8 articles
No recent mentions
Revolution Medicines' Experimental Drug Doubles Survival in Early Pancreatic Cancer Trials
Researchers report that Revolution Medicines' experimental drug, daraxonrasib, significantly extends survival in early pancreatic cancer patients. This breakthrough offers hope in a field where prognosis has been traditionally grim, and further testing is underway to validate these findings.
· 44d ago
Ben Sasse Enrolls in Pancreatic Cancer Clinical Trial After Diagnosis
Former senator Ben Sasse has joined a clinical trial for metastatic pancreatic cancer after a grim diagnosis, seeking potential life extension options. The trial’s promising results, nearly doubling patient survival, could define future treatment approaches.
· 52d ago